[FWP] Forward Pharma A/S

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 925.21 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 15.49 Change: 0.19 (1.24%)
Ext. hours: Change: 0 (0%)

chart FWP

Refresh chart

Strongest Trends Summary For FWP

FWP is in the medium-term down -76% in 4 months. In the long-term down -78% below S&P in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding46.87 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV-511.17 Price/Cash Per Share
Price/Free Cash Flow ROA-292.83% ROE469.34% ROI
Current Ratio0.61 Quick Ratio Long Term Debt/Equity Debt Ratio-2.6
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities-130 K Cash From Operating Activities-5.08 M Gross Profit
Net Profit5.26 M Operating Profit-8.39 M Total Assets208.56 M Total Current Assets84.23 M
Total Current Liabilities4.53 M Total Debt Total Liabilities4.53 M Total Revenue
Technical Data
High 52 week5.36 Low 52 week0.73 Last close0.74 Last change1.37%
RSI7.14 Average true range0.09 Beta0.83 Volume3.9 K
Simple moving average 20 days-29.25% Simple moving average 50 days-48.1% Simple moving average 200 days-68.47%
Performance Data
Performance Week-26% Performance Month-41.73% Performance Quart-71.86% Performance Half-73.67%
Performance Year-79.1% Performance Year-to-date-79.89% Volatility daily5.01% Volatility weekly11.19%
Volatility monthly22.94% Volatility yearly79.45% Relative Volume170.73% Average Volume46.36 K
New High New Low

News

2018-10-24 11:11:17 | Forward Pharma loses appeal in Tecfidera patent dispute with Biogen

2018-10-24 10:42:28 | Forward Pharma Provides Update on the Decision of the Federal Circuit in its Appeal of the U.S. Patent Interference

2018-09-28 07:30:00 | Forward Pharma to Participate in the Ladenburg Thalmann 2018 Healthcare Conference

2018-09-20 09:02:32 | The Daily Biotech Pulse: Adverum Snags Fast Track Designation, Crispr To Offer Shares, Elanco Animal Health To Debut

2018-09-19 16:20:00 | Forward Pharma Reports Financial and Operational Results from the First Six Months of 2018

2018-08-23 08:00:00 | Forward Pharma to Participate in the LSX Nordic Congress

2018-05-23 08:20:00 | Today's Research Reports on Trending Tickers: Geron and Forward Pharma

2018-05-07 16:30:00 | Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent

2018-04-30 16:40:00 | Forward Pharma Reports Full-Year 2017 Financial and Operational Results

2018-02-07 07:30:00 | Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference

2018-01-29 10:44:33 | Forward Pharma Announces the Decision of the European Patent Office in the Opposition Proceedings for the EP2801355 Patent

2017-12-21 17:00:00 | Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interference to the Federal Circuit

2017-11-29 16:30:00 | Forward Pharma Files Further Written Submissions in the European Opposition Proceeding for the EP2801355 Patent in Preparation for the Oral Hearing in January 2018

2017-11-27 07:30:00 | Forward Pharma to Participate in Investor Conferences in December

2017-11-22 16:30:00 | Forward Pharma Announces Completion of Corporate Restructuring Plan

2017-11-15 08:02:27 | Best-In-Class Undervalued Stocks

2017-11-09 16:30:00 | Forward Pharma to Participate in the Nordic-American Life Science Conference

2017-10-09 07:40:00 | Featured Company News - AVEO Declares Completion of TIVO-3 Study Futility Analysis

2017-09-26 16:15:00 | Forward Pharma Reports Financial and Operational Results from the First Six Months of 2017

2017-09-13 08:10:00 | Today's Research Reports on Stocks to Watch: Atossa Genetics and Forward Pharma

2017-09-08 08:56:42 | Is It Time To Buy Forward Pharma A/S FWP?

2017-09-05 17:00:00 | Forward Pharma Files Opening Brief in the Appeal of the U.S. Patent Interference to the Federal Circuit

2017-09-01 07:00:00 | Forward Pharma Board of Directors Approves Capital Reduction and Returns EUR 917.7 Million to Shareholders

2017-08-02 16:45:00 | Forward Pharma Obtains Shareholder Approval of the Planned Capital Reduction at the Extraordinary General Meeting

2017-07-18 08:05:00 | Forward Pharma announces planned distribution of EUR 19.45 per share to Shareholders

2017-06-14 08:00:00 | Forward Pharma CEO to Present at the JMP Securities 2017 Life Sciences Conference on June 20, 2017

2017-06-02 08:30:00 | Forward Pharma CEO to Present at the Jefferies 2017 Global Healthcare Conference on June 6, 2017

2017-05-31 08:30:00 | Forward Pharma Appeals the Initial Decision in the U.S. Patent Interference to the Federal Circuit

2017-05-01 08:30:00 | Forward Pharma CEO to Present at the 42nd Annual Deutsche Bank Health Care Conference on May 4, 2017

2017-05-01 07:30:00 | Forward Pharma Further Aligns Cost Structure with Focus Following Settlement and License Agreement

2017-04-07 08:33:12 | Should Forward Pharma FWP Be On Your Radar Now?

2017-04-03 06:26:57 | Forward Pharma A/S downgraded by JMP Securities and Jefferies

2017-03-31 17:14:00 | Why Acorda Therapeutics Inc and Forward Pharma A/S Got Crushed Today

2017-03-31 14:45:06 | ?Biogen wins another big Tecfidera patent case

2017-03-31 13:02:22 | Biogen wins Tecfidera U.S. patent dispute with Forward Pharma

2017-03-31 12:27:01 | Biogen stock rises, Forward Pharma halted down 20% after patent ruling

2017-03-31 12:15:35 | Forward Pharma Falls On Biogen Patent Victory Over MS Drug Ingredient

2017-03-31 12:10:00 | Forward Pharma plunges on patent ruling

2017-03-01 09:15:00 | Forward Pharma Appoints Claus Bo Svendsen as Chief Executive Officer and Plans to Reorganize to Reduce Burn Rate Following the Settlement and License Agreement with Biogen

2017-02-09 08:30:00 | Forward Pharma Received US$ 1.25bn pursuant to Settlement and License Agreement with Biogen

2017-02-03 11:03:08 | Why Forward Pharma A/S Stock Surged 107% in January

2017-02-02 09:30:02 | The Zacks Analyst Blog Highlights: Forward Pharma A/S, Pioneer Power Solutions, Hudbay Minerals, Applied Optoelectronics and Ultra Clean Holdings

2017-02-01 09:15:00 | Forward Pharma Announces Results of Extraordinary General Meeting

2017-01-26 06:41:05 | Biogen profit drops 22 pct due to Tecfidera-related costs

2017-01-18 12:46:02 | Biogen Inc. -- Moody's: Biogen's settlement with Forward Pharma is credit negative

2017-01-18 08:29:47 | Why Forward Pharma A/S Stock Gained 48.2% on Tuesday

2017-01-18 08:02:01 | Biogen to Pay $1.25B to Forward Pharma in Tecfidera Lawsuit

2017-01-17 11:05:41 | Tuesday’s Top Biopharma Movers

2017-01-17 11:01:45 | Forward Pharma Agrees to Enter Into Settlement and License Agreement with Biogen

2017-01-17 10:05:07 | Biogen to pay $1.25B settlement in multiple sclerosis drug case